​MCA Licensee Guidance

Edible Cannabis Pr​​oduct Exemption Application Process and Requirements

In order for a product to be considered for an edible cannabis product exemption, a licensed processor must meet the requirements of COMAR On January 27, 2022, the MCA clarified the requirements under COMAR A copy of the resolution adopted by the MCA regarding edible cannabis product exemption requirements may be viewed here​​.

List of Approved Products under COMAR
The MCA has voted on exempting certain products that meet the requirements of COMAR, as clarified through the resolution adopted at the meeting on January 27, 2022. The current list of products may be viewed ​here​​​.​ Note: this list will be updated as the MCA considers additional products.

Edible Cannabis Product Exemption Application
In order for the MCA to consider a request to exempt an edible cannabis product from COMAR, a licensed processor must submit a complete edible cannabis product exemption application, including all required supporting documents. A complete application will be presented to the MCA for their consideration. A product may not be exempted unless approved by the MCA members in an open meeting. The application form may be accessed here​. Please direct any questions to mca.product.approvals@maryland.gov​​​.

MCA Fine Schedule

The document linked here​ contains a list of civil money penalties approved by MCA on November 17, 2020, in accordance with COMAR

Edible Cannabis Products

Regulations establishing the framework for the processing and distribution of edible cannabis products will be effective on April 19, 2021.​

Packaging and Labeling

This guidance document provides information on new and updated requirements for the packaging and labeling of medical cannabis, including edible cannabis products.

Form and Dosage

Form and Dosage​

This guidance document provides information on:

  • Categorization of cannabis-infused products and edible cannabis products, and
  • Restrictions on product form and dosage.

Ownership and Control of a Medical Cannabis License
Ownership and Control Requirements​

The guidance document provides information on (click here​):

  • The process, requirements, and restrictions for the transfer of an ownership interest and/or control of a medical cannabis license; and
  • The required disclosures of ownership and control of a medical cannabis license.

Hemp Acquisition

Acquisition of Hemp – FAQs​

  • Pursuant to COMAR and, licensed processors and dispensaries may obtain hemp from sources outside the seed-to-sale system (METRC) under certain circumstances.
  • Additional information for obtaining hemp, as well as information on testing requirements, and the sale of CBD products can be found in the FAQs.

Clinical Director

Clinical Director Guidance Document​​​​

The guidance document provides information on:

  • Who is eligible to serve as a clinical director;
  • The responsibilities of a clinical director;
  • Clinical director reporting and training requirements; and
  • The process to register as a clinical director.

Video Surveillance, Inventory Control, and Inspections

Gui​dance Document

The guidance document provides information on:

  • Video surveillance requirements for licensee premises;
  • Theft and diversion reporting requirements; and
  • Requirements for inventory tracking and entry of sales data.